Amgen is launching a major new project to expand its research capabilities in the United States with a $600 million investment in a state-of-the-art Science & Innovation Hub. Located at the company’s global headquarters in Thousand Oaks, California, the new facility is designed to strengthen collaboration, enhance digital innovation, and push the boundaries of biotechnology research and development.
This project reflects not only Amgen’s growth as a global biopharmaceutical company but also its commitment to building a more resilient, future-ready U.S. life sciences ecosystem.
The Amgen Science & Innovation Hub will be a cutting-edge research and development center focused on accelerating drug discovery and advancing science. The facility will be designed to bring scientists, engineers, and data experts together under one roof, creating a modern environment that supports creativity and problem-solving.
This new hub will serve as the foundation for the next generation of Amgen’s innovation. With advanced tools, digital systems, and automation, researchers will be able to reduce development times, collaborate more effectively, and ultimately get therapies to patients faster.
Over the past several years, Amgen has significantly expanded its investment in American manufacturing and R&D. Since 2018, the company has committed over $40 billion to domestic projects. This new facility in California continues that trend, further anchoring Amgen’s long-term vision in the U.S.
Amgen’s decision comes at a time when there is a national push for companies to expand their presence on American soil. With growing geopolitical tensions, supply chain risks, and tariff uncertainties, many life sciences firms are making similar moves to bring operations closer to home.
Construction of the Science & Innovation Hub is expected to begin in the second half of 2025. Once operational, the facility will create hundreds of highly skilled jobs, including roles for scientists, lab technicians, engineers, and IT professionals.
Beyond direct hiring, the project will also contribute to local job growth in construction, equipment supply, and ongoing facility operations.
With more integrated technology and collaboration, the new hub will help Amgen bring therapies to patients more efficiently. This is especially important in therapeutic areas like oncology, cardiology, and rare diseases, where speed and precision in research can save lives.
The Science & Innovation Hub is being designed with a forward-looking approach that blends modern architecture with scientific utility. Some of the key features expected include:
The facility will support both early-stage research and later-stage development, helping Amgen accelerate the full product pipeline from discovery to clinical trials.
The new Science & Innovation Hub is just one piece of a much larger plan. Amgen has been actively expanding its U.S. operations over the past few years with major investments across the country. Notable projects include:
By spreading its investments across different regions, Amgen is building a decentralized and resilient ecosystem for research, development, and production.
Thousand Oaks has been Amgen’s home base for more than four decades, and this new investment reaffirms its commitment to the local community. The project will contribute significantly to California’s already strong biotech industry, bringing in new jobs, academic partnerships, and potential startup collaborations.
The facility is expected to act as a magnet for scientific talent, attracting professionals from across the country and around the world.
Amgen’s $600 million investment sends a clear signal that the U.S. remains a key player in global pharmaceutical innovation. By keeping core R&D operations at home, the company is helping ensure that the United States remains competitive in areas like precision medicine, biologics, and data-driven drug discovery.
It also demonstrates how public policy—such as pro-growth tax laws and bipartisan innovation incentives—can drive meaningful private sector investment in research and development.
Amgen’s move mirrors a broader trend in the life sciences industry. Many global drugmakers are expanding their U.S. footprints to strengthen supply chains and prepare for possible future trade shifts.
Analysts see the Science & Innovation Hub as a smart strategic move. It reflects an understanding that the future of biotech depends not just on innovation, but on agility, integration, and real-time collaboration.
While Amgen has not released the full timeline for project completion, early signs suggest the hub could be operational by the end of the decade, depending on construction progress and regulatory approvals.
The Science & Innovation Hub represents more than just a building project. It’s a clear symbol of what the future of biotech could look like—collaborative, digital-first, and globally impactful.
As biotechnology continues to evolve, the ability to innovate quickly and responsibly will become more important than ever. Amgen is positioning itself to lead that charge with infrastructure designed for the challenges and opportunities of tomorrow.
As construction begins, Amgen will likely release more details about the scope and capabilities of the new center. Here are a few things to watch for:
For now, the $600 million Science & Innovation Hub is one of the most significant biotech infrastructure projects underway in the U.S., and it may set the standard for how life sciences companies approach research in the coming decades.
Amgen’s new Science & Innovation Hub marks a major milestone in the company’s ongoing mission to deliver life-changing medicines through scientific excellence. With a $600 million investment, this advanced facility is poised to transform how research is conducted and how therapies are developed.
By combining automation, data science, collaboration, and sustainability, the hub will help drive faster, more precise breakthroughs in medicine. It’s not just a building—it’s a bold step into the future of biotech, rooted in American innovation and aimed at global impact.
Do Follow USA Glory On Instagram
Read Next – Freedom Cities Blueprint: Deregulated New American Communities
The University of Pittsburgh, commonly known as Pitt, has maintained its position as 32nd among…
Troy University has been recognized by U.S. News & World Report as one of the…
Salisbury University has recently been recognized as one of the best colleges in the United…
In a significant development, Hamas has announced that it will release all remaining hostages held…
In a recent statement, President Trump urged Israel to “immediately stop” bombing Gaza, emphasizing his…
U.S. financial markets experienced notable movements as Treasury yields ticked higher and crude oil prices…